Inflammatory mechanisms and intervention strategies for sepsis-induced myocardial dysfunction

Yuxin Nong1, Xuebiao Wei2, Danqing Yu1

  • 1Department of Cardiology, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.

Insights

Sepsis-induced myocardial dysfunction (SIMD) remains a major cause of death. Understanding the complex inflammatory mechanisms and exploring new therapies are crucial for improving patient outcomes in sepsis.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Immunology

Background:

  • Sepsis-induced myocardial dysfunction (SIMD) is a primary cause of mortality in intensive care units.
  • SIMD presents as systolic and diastolic cardiac dysfunction, with persistently high incidence and mortality rates.
  • Despite decades of research, the heterogeneity of sepsis, pathogens, and host factors complicates SIMD understanding.

Purpose of the Study:

  • To review the complex inflammatory mechanisms underlying sepsis-induced myocardial dysfunction.
  • To explore potential novel therapeutic strategies for managing SIMD.

Main Methods:

  • Literature review of recent studies on SIMD.
  • Analysis of inflammatory responses in sepsis and their impact on cardiac function.
  • Identification and discussion of emerging therapeutic approaches.

Main Results:

  • SIMD is increasingly recognized as a multifactorial condition, not solely due to excessive inflammation.
  • Inflammatory responses between the pathogen and host significantly shape SIMD development.
  • Novel therapeutic strategies are being investigated to target these complex mechanisms.

Conclusions:

  • A comprehensive understanding of SIMD requires considering the interplay of pathogen, host, and inflammatory factors.
  • Targeting these intricate inflammatory pathways offers promising avenues for future SIMD therapies.
  • Further research into novel treatments is essential to reduce the high mortality associated with SIMD.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
12
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
13
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
15
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
17